Publication
Management of von Willebrand disease type 3 during pregnancy - 2 cases reports.
| dc.contributor.author | Inocêncio, G. | |
| dc.contributor.author | Braga, A. | |
| dc.contributor.author | Azevedo, S. | |
| dc.contributor.author | Buchner, C | |
| dc.date.accessioned | 2014-09-22T11:19:46Z | |
| dc.date.available | 2014-09-22T11:19:46Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | BACKGROUND: von Willebrand disease type 3, is an extremely rare condition. It can be severe and potentially life-threatening, particularly in pregnant women during labor and subsequently during early puerperium. Due to its rarity, there is no optimal treatment/management during pregnancy. CASE: We describe two cases of pregnant women with von Willebrand disease type 3, and its successful surveillance and treatment with Haemate P FVIII (human plasma-derived von Willebrand Factor-ristocetin co-factor associated with human coagulation factor VIII), during pregnancy, partum and puerperium. CONCLUSIONS: Daily prophylaxis with Haemate P FVIII in women with von Willebrand disease type 3, starting 2 hours before caesarean section until the 7th day of puerperium, associated with close analytical and clinical surveillance seems to be a safe clinical option. | por |
| dc.identifier.citation | Eur Rev Med Pharmacol Sci. 2013 Nov;17(21):2857-9. | por |
| dc.identifier.issn | 1128-3602 | |
| dc.identifier.issn | 2284-0729 (Electronic) | |
| dc.identifier.uri | http://hdl.handle.net/10400.16/1684 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Verduci | por |
| dc.relation.publisherversion | http://www.europeanreview.org/article/5788 | por |
| dc.subject | von Willebrand disease | por |
| dc.subject | Type 3 | por |
| dc.subject | Pregnancy | por |
| dc.subject | Management | por |
| dc.title | Management of von Willebrand disease type 3 during pregnancy - 2 cases reports. | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Italy | por |
| oaire.citation.endPage | 2859 | por |
| oaire.citation.startPage | 2857 | por |
| oaire.citation.title | European Review for Medical and Pharmacological Sciences | por |
| oaire.citation.volume | 17(21) | por |
| rcaap.rights | openAccess | por |
| rcaap.type | article | por |